Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Motyl

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|January 26, 2006
What are we looking for in new antibacterials and how do we design it?John F Barrett, Mary Motyl
Current Protocols in Pharmacology|September 29, 2011
Basic microbiological techniques used in antibacterial drug discoveryMary Motyl, Karen Dorso, John Barrett, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in cultureJennifer Nielsen Kahn, Ming-Jo Hsu, Fred Racine, et al.
BMC Microbiology|June 13, 2023
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020David W Hilbert, C Andrew DeRyke, Mary Motyl, et al.
Diagnostic Microbiology and Infectious Disease|June 29, 2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infectionsBarbara A Pelak, Ken Bartizal, Gail L Woods, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2002
Use of surrogate antimicrobial agents to predict susceptibility to ertapenemIan R Friedland, Robin Isaacs, Lori A Mixson, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Synthesis and antifungal evaluation of pentyloxyl-diphenylisoxazoloyl pneumocandins and echinocandinsSheo B Singh, Kithsiri Herath, Jennifer Nielsen Kahn, et al.
Clinical Therapeutics|May 29, 2016
Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012-2013)Magdalena Zalacain, Douglas J Biedenbach, Robert E Badal, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcomeNicholas Kartsonis, John Killar, Lori Mixson, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infectionBarbara A Pelak, Diane M Citron, Mary Motyl, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|January 26, 2006
What are we looking for in new antibacterials and how do we design it?John F Barrett, Mary Motyl
Current Protocols in Pharmacology|September 29, 2011
Basic microbiological techniques used in antibacterial drug discoveryMary Motyl, Karen Dorso, John Barrett, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in cultureJennifer Nielsen Kahn, Ming-Jo Hsu, Fred Racine, et al.
BMC Microbiology|June 13, 2023
Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018-2020David W Hilbert, C Andrew DeRyke, Mary Motyl, et al.
Diagnostic Microbiology and Infectious Disease|June 29, 2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infectionsBarbara A Pelak, Ken Bartizal, Gail L Woods, et al.
Diagnostic Microbiology and Infectious Disease|June 8, 2002
Use of surrogate antimicrobial agents to predict susceptibility to ertapenemIan R Friedland, Robin Isaacs, Lori A Mixson, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Synthesis and antifungal evaluation of pentyloxyl-diphenylisoxazoloyl pneumocandins and echinocandinsSheo B Singh, Kithsiri Herath, Jennifer Nielsen Kahn, et al.
Clinical Therapeutics|May 29, 2016
Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012-2013)Magdalena Zalacain, Douglas J Biedenbach, Robert E Badal, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcomeNicholas Kartsonis, John Killar, Lori Mixson, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infectionBarbara A Pelak, Diane M Citron, Mary Motyl, et al.
Pageof 5